Showing results (11-20 of 167) with videos related to

Sort By:
Pageof 17
Endocrine-Related Cancer|October 14, 2017
Endocrine side effects of cancer immunotherapyPriscilla Cukier, Fernando C Santini, Mariana Scaranti, et al.
Cancer Immunology Research|July 12, 2018
Safety and Efficacy of Re-treating with Immunotherapy after Immune-Related Adverse Events in Patients with NSCLCFernando C Santini, Hira Rizvi, Andrew J Plodkowski, et al.
Journal for Immunotherapy of Cancer|July 4, 2014
Opportunistic infections in patients treated with immunotherapy for cancerChrisann Kyi, Matthew D Hellmann, Jedd D Wolchok, et al.
The Annals of Thoracic Surgery|August 26, 2017
Initial Experience With Lung Cancer Resection After Treatment With T-Cell Checkpoint InhibitorsJamie E Chaft, Matthew D Hellmann, Moises J Velez, et al.
Cancer Discovery|May 14, 2020
Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung CancersJia Luo, Hira Rizvi, Jacklynn V Egger, et al.
Clinical Imaging|February 10, 2022
Radiogenomics in personalized management of lung cancer patients: Where are we?Jose Arimateia Batista Araujo-Filho, Maria Mayoral, Natally Horvat, et al.
JTO Clinical and Research Reports|September 30, 2021
Association Between the Early Discontinuation of Durvalumab and Poor Survival in Patients With Stage III NSCLCNarek Shaverdian, Michael Offin, Annemarie F Shepherd, et al.
IEEE Transactions on Medical Imaging|July 25, 2018
Multiple Resolution Residually Connected Feature Streams for Automatic Lung Tumor Segmentation From CT ImagesJue Jiang, Yu-Chi Hu, Chia-Ju Liu, et al.
JTO Clinical and Research Reports|July 3, 2026
Clinical Outcomes for Patients who Received Both Trastuzumab Deruxtecan (T-DXd) and Trastuzumab Emtansine (T-DM1) for HER2-Mutant non-Small Cell Lung CancerDaniel Reinhorn, Jonathan Kuten, Isabel Preeshagul, et al.
Pageof 17